MARTHA BOOCHIE: Open Payments
NPI 1083463996 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 24 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $271 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $295 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $166 |
| Teva Pharmaceuticals USA, Inc. | 4 | $132 |
| Almatica Pharma LLC | 2 | $58 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $35 |
| ABBVIE INC. | 2 | $34 |
Products named: COBENFY, CAPLYTA, AUSTEDO XR, LOREEV XR, INGREZZA, REXULTI, VRAYLAR.
Industry payments across CA — which companies pay providers there.
